NDAORALTABLET
Approved
Nov 2020
Lifecycle
Peak
Competitive Pressure
0/100
Data completeness
3/8 — Basic
Drug data last refreshed 16h ago · AI intelligence enriched 19h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
SUTAB is an oral tablet formulation containing sodium sulfate, magnesium sulfate, and potassium chloride, a bowel preparation agent used to cleanse the colon prior to colonoscopy and other GI procedures. It works by inducing osmotic laxation to evacuate intestinal contents. The tablet form offers improved patient compliance compared to traditional liquid formulations.
$29MPart D
Peak10.7 years to LOESUTAB is in peak commercial phase with $29M in Part D spending and 173K claims annually; moderate-sized brand teams focused on maximizing market penetration before patent expiry.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on SUTAB offers exposure to specialty pharmaceutical commercialization within gastroenterology, with emphasis on driving adoption through managed care and hospital channels. The brand's peak lifecycle and competitive advantage position offer stable career growth in brand management and field-based roles, though limited clinical development opportunities exist.
Brand Manager
Worked on SUTAB at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.